• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Slides for the June 8-9, 2010 meeting of Tobacco Products Constituents Subcommittee of TPSAC

DISCLAIMER: The information in these materials is not a formal dissemination of information by FDA and does not represent agency position or policy. The information is being provided to TPSAC to aid the committee in its evaluation of the issues and questions referred to the committee.


June 8, 2010 Slides 


Charge to the Group: Harmful and Potentially Harmful Tobacco Product Constituent


Corinne Husten, M.D., M.P.H.
Center for Tobacco Products, FDA


Examples of Lists of Harmful/Potentially Harmful Constituents and the Rationale for Inclusion






Patricia Richter, Ph.D.
Office on Smoking and Health
National Center for Chronic Disease Prevention and Health Promotion
Centers for Disease Control and Prevention


Industry Presentations: Preliminary Information Concerning the Establishment of a List of Harmful and Potentially Harmful Tobacco Product Constituents










Michael W. Ogden, Ph.D.
R. J. Reynolds Tobacco Company
(On behalf of multiple tobacco product manufacturers)


David Michael Johnson, Ph.D.
Council of Independent Tobacco
Manufacturers of America (CITMA)




Carcinogen Classification CriteriaPatricia Richter, Ph.D.



Open Public Hearing

List of Speakers

Slides for Lanier & Wright

Slides for Higby

Slides for Lane






Proposed Methodology Options for Analysis of




Clifford O. Watson, Ph.D.
National Center for Environmental Health
Centers for Disease Control and Prevention


June 9, 2010


Summary Table of Example Government or WHO Lists(provided in the background materials)
List by Indication:Final Version

Draft Proposed Initial List of Harmful/Potentially Harmful Constituents in Tobacco Products, including Tobacco Smoke
Final Version